(Q40685524)

22 September 2017

title

Open comparison of mefloquine, mefloquine/sulfadoxine/pyrimethamine and chloroquine in acute uncomplicated falciparum malaria in children (English)

1 reference

22 September 2017

0 references

0 references

Plasmodium falciparum

0 references

0 references

1 reference

1

Sowunmi A

1 reference

22 September 2017

2

Oduola AM

1 reference

22 September 2017

A. M. Oduola

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7660443

27 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7660443

27 July 2024

publication date

1 May 1995

1 reference

full work available at URL

22 September 2017

http://academic.oup.com/trstmh/article-pdf/89/3/303/5332585/89-3-303.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1016/0035-9203(95)90554-5

Transactions of the Royal Society of Tropical Medicine and Hygiene

27 July 2024

published in

1 reference

22 September 2017

volume

89

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

303-305

1 reference

Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria

22 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0035-9203(95)90554-5

Reduced in-vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparum

27 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/0035-9203(95)90554-5

Innate resistance to new antimalarial drugs in Plasmodium falciparum from Nigeria

27 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/0035-9203(95)90554-5

Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique

27 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/0035-9203(95)90554-5

Reduced in vitro susceptibility to halofantrine of Plasmodium falciparum in West Africa

27 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/0035-9203(95)90554-5

Evaluation of the clinical efficacy and safety of halofantrine in falciparum malaria in Ibadan, Nigeria

27 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/0035-9203(95)90554-5

Reduced sensitivity of Plasmodium falciparum to mefloquine in West Africa.

27 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/0035-9203(95)90554-5

Evaluation of the relative efficacy of various antimalarial drugs in Nigerian children under five years of age suffering from acute uncomplicated falciparum malaria

27 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/0035-9203(95)90554-5

Pruritus and antimalarial drugs in Africans

27 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/0035-9203(95)90554-5

Clinical efficacy of mefloquine in children suffering from chloroquine-resistant Plasmodium falciparum malaria in Nigeria

27 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/0035-9203(95)90554-5

The relationship between the response of Plasmodium falciparum malaria to mefloquine in African children and its sensitivity in vitro

27 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/0035-9203(95)90554-5

Neuropsychiatric side effects of mefloquine in Africans

27 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/0035-9203(95)90554-5

Intramuscular sulfadoxine-pyrimethamine in uncomplicated chloroquine-resistant falciparum malaria during pregnancy

27 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/0035-9203(95)90554-5

Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma

27 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/0035-9203(95)90554-5

27 July 2024

Identifiers

1 reference

22 September 2017

1 reference